万隆制药 (873617.OC)

+ 收藏

利润表(万隆制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 111,518,731.22272,102,670.57147,673,532.62403,554,265.80185,532,707.59
 营业收入(元) 111,518,731.22272,102,670.57147,673,532.62403,554,265.80185,532,707.59
二、营业总成本(元) 97,383,632.87321,742,058.08180,393,742.55421,500,442.25199,050,974.62
 营业成本(元) 36,461,276.8480,565,811.7735,386,232.6979,649,097.2534,546,024.80
 研发费用(元) 5,423,504.1620,107,367.7212,098,392.0517,125,858.608,258,553.85
 营业税金及附加(元) 3,087,225.606,362,323.283,617,867.178,320,741.343,485,294.84
 销售费用(元) 33,913,188.33173,398,896.38110,211,323.28279,852,623.94136,379,599.81
 管理费用(元) 17,374,563.3740,554,044.2918,860,449.9735,485,976.9116,053,872.52
 财务费用(元) 1,123,874.57753,614.64219,477.391,066,144.21327,628.80
  其中:利息费用(元) 1,222,291.66983,500.00343,000.001,237,249.88453,249.99
  其中:利息收入(元) 93,069.56232,309.81126,847.56179,267.85133,130.81
三、其他经营收益
 资产减值损失(元) -8,066,835.69-33,260,297.23-5,108,093.46-16,387,702.56-2,950,364.44
 信用减值损失(元) 28,305.051,389,405.87398,737.1819,695.27-61,407.33
 其他收益(元) 7,130,559.295,383,179.141,541,867.297,181,135.132,392,991.08
四、营业利润(元) 13,227,127.00-76,127,099.73-35,887,698.92-27,133,048.61-14,137,047.72
 加:营业外收入(元) 81,264.3187,831.183,463.29415,276.95266,443.45
 减:营业外支出(元) 130,380.24247,867.96126,173.5833,796.2830,700.00
五、利润总额(元) 13,178,011.07-76,287,136.51-36,010,409.21-26,751,567.94-13,901,304.27
 减:所得税费用(元) -26,899.37-53,798.73-26,899.36-53,798.72-26,899.38
六、净利润(元) 13,204,910.44-76,233,337.78-35,983,509.85-26,697,769.22-13,874,404.89
(一)按经营持续性分类
  持续经营净利润(元) 13,204,910.44-76,233,337.78-35,983,509.85-26,697,769.22-13,874,404.89
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 13,204,910.44-76,233,337.78-35,983,509.85-26,697,769.22-13,874,404.89
 扣除非经常性损益后的净利润(元) 6,770,048.24-79,839,240.87-374,494,420.28-34,250,932.40-16,099,376.62
七、每股收益
 一、基本每股收益(元) 0.18-1.02-0.48-0.36-0.19
 二、稀释每股收益(元) 0.18-1.02-0.48-0.36-0.19
九、综合收益总额(元) 13,204,910.44-76,233,337.78-35,983,509.85-26,697,769.22-13,874,404.89
 归属于母公司所有者的综合收益总额(元) 13,204,910.44-76,233,337.78-35,983,509.85-26,697,769.22-13,874,404.89
公告日期 2024-08-272024-04-252023-08-252023-04-252022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院